Mylan Captopril 12,5 mg/ 25 mg / 50 mg White capsule-shaped tablet
PDF Leaflet Revision Date: 18 October 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of mild to moderate hypertension and congestive heart failure.
Dosage (summary)
Initial: 25 mg 2-3 times daily; max: 150 mg/day.
Special Populations
- Renal impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy; safety in breastfeeding not established.
Key Drug Interactions
- Potassium-sparing diuretics
- Lithium
- NSAIDs
Contraindications
- Hypersensitivity to captopril
- History of angioedema
- Severe renal impairment
Common side effects
- Cough
- Dizziness
- Hyperkalaemia
Counselling Points
- Take 1 hour before meals
- Monitor blood pressure regularly
- Report signs of infection
Serious warnings
- Risk of hypotension in volume-depleted patients
- Angioedema risk
Important Disclaimer
The Mylan Captopril 12,5 mg/ 25 mg / 50 mg White capsule-shaped tablet professional information leaflet below is the property of Viatris Healthcare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
